Hyperoxaluria
📧 Sign up to get email alerts when something new happens for Hyperoxaluria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-06-11Clinical Trial Update: A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria [Phase 1]
BioMarin's BMN-255 Phase 1 trial in hyperoxaluria with nonalcoholic fatty liver disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-01-05Clinical Trial Update: A Trial of Pyridoxamine to Lower Urine Oxalate in Subjects With Stone Disease or Hyperoxaluria [Phase 2]
A Phase 2 trial investigating pyridoxamine to reduce urine oxalate in people with nephrolithiasis or hyperoxaluria has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-07Clinical Trial Update: International Registry for Primary Hyperoxaluria
The International Registry for Primary Hyperoxaluria, sponsored by Mayo Clinic, has been withdrawn from clinical trials.
-
CLINICAL_TRIALS withdrawal · 2015-04-07Clinical Trial Update: Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria [Phase 3]
A Phase 3 trial evaluating whether ACE inhibitors and ARBs can provide renal protection in primary hyperoxaluria was withdrawn.